↓ Skip to main content

Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor

Overview of attention for article published in Cell Chemical Biology, April 2021
Altmetric Badge

Mentioned by

twitter
21 X users
patent
1 patent

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
Published in
Cell Chemical Biology, April 2021
DOI 10.1016/j.chembiol.2021.04.004
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 13%
Student > Master 5 10%
Student > Doctoral Student 4 8%
Student > Bachelor 4 8%
Student > Ph. D. Student 3 6%
Other 8 17%
Unknown 18 38%
Readers by discipline
Readers by discipline Count As %
Chemistry 16 33%
Biochemistry, Genetics and Molecular Biology 4 8%
Medicine and Dentistry 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Social Sciences 2 4%
Other 5 10%
Unknown 15 31%